Efficacy of Vedolizumab as Induction Therapy in Refractory IBD Patients

Autor: Edward Shelton, Ashwin N. Ananthakrishnan, Jenny Sauk, John J. Garber, Cosmas Giallourakis, Sonia Friedman, Punyaganie de Silva, Jessica R. Allegretti, Betsy W. Stevens, Fredrick Makrauer, Matthew J. Hamilton, Jonathan S. Levine, Deanna D. Nguyen, Joshua R. Korzenik, Michal Tomczak, Hamed Khalili, Robert Burakoff, Vijay Yajnik, Matthew B. Lucci

Publikováno v: Inflammatory Bowel Diseases. 21:2879-2885

Background Vedolizumab (VDZ) demonstrated efficacy in Crohn's disease (CD) and ulcerative colitis (UC) in the GEMINI trials. Our aim was to evaluate the efficacy of VDZ at week 14 in inflammatory bowel disease in a multicenter cohort of patients. Met

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::452c13be97853a3527426178796ee0a3
https://doi.org/10.1097/mib.0000000000000561

Fits of weeping as an unusual manifestation of reflex epilepsy induced by speaking: case report

Autor: D Romito, E Del Zotto, C Marchini, B Lucci

Publikováno v: Acta Neurologica Scandinavica. 90:218-221

We report the case of a 62-year-old man with no past CNS history who for some weeks had had fits of weeping that lasted from 30" to 3', precede by any aura; sensorium was clear; there were no symptoms of any kind after the paroxysm; in the course of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b42f52a0d81aa65eaac5f066d78a228b
https://doi.org/10.1111/j.1600-0404.1994.tb02709.x

Factors Associated with Durable Response to Infliximab in Crohn's Disease 5 Years and Beyond: A Multicenter International Cohort

Autor: Bernard Burnand, Harry Sokol, Pascal Juillerat, Matthew B. Lucci, Florian Froehlich, Jacques Cosnes, Laurent Beaugerie, Vijay Yajnik, Andrew J. Macpherson, Joshua R. Korzenik

Publikováno v: Inflammatory Bowel Diseases
Inflammatory Bowel Diseases, 2014, 21 (1), pp.60-70. ⟨10.1097/MIB.0000000000000225⟩
Inflammatory Bowel Diseases, Lippincott, Williams & Wilkins, 2014, 21 (1), pp.60-70. ⟨10.1097/MIB.0000000000000225⟩

BACKGROUND: Infliximab (IFX) has been used for over a decade worldwide. Less is known about the natural history of IFX use beyond a few years and which patients are more likely to sustain benefits. METHODS: Patients with Crohn's disease (CD) exposed

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0147e3e2c2675ac1f28ad43d87166a3
https://hal.science/hal-01097180

Multiple sclerosis in twins from continental Italy and Sardinia: a nationwide study

Autor: Ristori G, Cannoni S, Stazi MA, Vanacore N, Cotichini R, Alfo M, Pugliatti M, Sotgiu S, Solaro C, Bomprezzi R, Di Giovanni S, Figa` Talamanca L, Nistico L, Fagnani C, Neale MC, Cascino I, Giorgi G, Battaglia MA, Buttinelli C, Tosi R, Salvetti M, M. Melato, R. Dellantonio, L. Sironi, E. Bottacchi, M. Signorino, R. Angeloni, L. Curatola, C. Paci, M. Ragno, G. Sirocchi, AM. Vurchio, E. Duc, D. Spitaleri, M. Trojano, M. Liguori, N. Cimini, G. Moretto, M. Porta, MR Rottoli A. Mamoli, M. Camerlingo, E. Nardozza, T. Sacquegna, S. Stecchi, C. Scandellari, L. Callea, R. Capra, M. Codella, M. G. Marrosu, E. Cocco, A. Spissu, G. Cossu, S. Tronci, A. Di Lauro, E. Lombardi, A. Reggio, F. Patti, P. Valentino, A. Quattrone, D Farina, M. E. Nives, A. Lugaresi, F. Perla, M. G. Rosso, M. R. Tola, E. Granieri, MP Amato L. Massacesi, E. Millefiorini, V. Durastanti, G. L. Mancardi, A. Murialdo, NR. Pizio, P. Bellantonio, R. Fantozzi, R. Totaro, A. Carolei, F. Giramma, A. T. Lazzaro, C. Giraldi, M. Mazzoni, G. Giuliani, E. Pucci, P. Previdi, MC. Fazio, M. Buccafusca, P. Girlanda, C. Messina, G. D’Aleo, C. Milanese, L. Lamantia, D. Caputo, E. Scarpini, R. Clerici, L. Moiola, M. Gironi, E. Merelli, F. Casoni, S. Bonavita, G. Tedeschi, M. Leone, D. Mittino, SB. Murgia, L. Musu, P. Gallo, P. Perini, E. Frasson, G. Salemi, G. Cuccia, E. Montanari, L. Manneschi, D. Saviola, M. Antonelli, V. Cosi, R. Bergamaschi, V. Gallai, D. Murasecco, P. Sarchielli, R. Urcioli, G. Perticoni, G. Meucci, G. Moscato, B. Lucci, E. Covezzi, MG. Coniglio, D. Acquistapace, L. Motti, B. Dossi Curro`, M. Frontoni, C. Mainero, P. Giannetti, I. Pestalozza, S. Di Legge, M. Spadaro, C. Pozzilli, S. Romano, B. Mercuri, C. Scoppetta, C. Gasperini, S. Galgani, MG. Grasso, S. Paolucci, PA. Tonali, A. Leonardi, A. Oneto, G Rosati, M. A. Sotgiu, A. Bertolotto, M. Capobianco, L. Durelli, M. Clerico, L. Sosso, R. Bongioanni, D. Orrico, C. Carbonin, U. Freo. M. Zaffaroni, A. Ghezzi, N. Falcone

Publikováno v: Annals of neurology 59 (2006): 27–34. doi:10.1002/ana.20683
info:cnr-pdr/source/autori:Ristori G, Cannoni S, Stazi MA, Vanacore N, Cotichini R, Alfo M, Pugliatti M, Sotgiu S, Solaro C,Bomprezzi R, Di Giovanni S, Figa Talamanca L, Nistico L, Fagnani C, Neale MC, Cascino I, Giorgi G, Battaglia MA, Buttinelli C, Tosi R, Salvetti M./titolo:Multiple Sclerosis in Twins from Continental Italy and Sardinia: A Nationwide Study/doi:10.1002%2Fana.20683/rivista:Annals of neurology/anno:2006/pagina_da:27/pagina_a:34/intervallo_pagine:27–34/volume:59

Knowledge about the balance between heritable and nonheritable risk in multiple sclerosis (MS) is based on twin studies in high-prevalence areas. In a study that avoided ascertainment limitations and directly compared continental Italy (medium-preval

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::453c8b93c6b3690e3a79b1c0fd47ccd4
http://hdl.handle.net/11570/1943231

Subcortical brain functional alterations and cognitive disturbances in early RR-MS patients

Autor: L. GALLO, U. FREO, M. D. BENEDETTI, G. MORETTO, C. RAVENNA, B. LUCCI, G. GIGLI, N. RIZZUTO, V. TOSO, G. L. RICCHIERI, S. BUTTIGNOL, L. BATTISTIN, G. PIZZOLATO, NACCARATO, MARCELLO

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::74d2a92f5d5a9e6885923062b3d588e9
http://hdl.handle.net/11368/1689662